Bruker Corporation Stock Price and Value Analysis

Bruker Corporation (NASDAQ:BRKR) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Bruker Corporation to reach your target.

Target type

BRKR Free Cash Flow Trend

Free Cash Flow trendline for BRKR
Free Cash Flow trendline for Bruker Corporation
CSV

Based on historical returns, we believe that Bruker Corporation can grow its free cash at a rate of about 7%. That's positive!

AdvantagesDisadvantages
  • This company is making money at a decent rate.
  • This company is less known than others.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company has a low dividend yield.

Inside the BRKR Numbers

BRKR Price
(Bruker Corporation stock price per share)
$63.26
[?] BRKR Fair Price
(based on intrinsic value)
$16.08
[?] BRKR Safety Price (based on a variable margin of safety) $9.65
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 213% higher than other Technology stocks
[?] PE Ratio versus Industry 0% lower than other Scientific & Technical Instruments stocks
[?] Free Cash Flow Jitter 45%
[?] Dividend Yield 0.08% (tax impact)
Shares Shorted 11,251,178

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 11,251,178 shares shorted. With 104,049,761 shares available for purchase and an average trading volume over the past 10 trading days of 2,894,990, it would take at least 3.9 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 1109354 134
2010 1109354 132
2011 1109354 51.1
2012 1109354 87.5
2013 1109354 98.4
2014 1109354 64.2
2015 1109354 179
2016 1109354 85.2
2017 1109354 115
2018 1109354 200
2019 1109354 178
2020 1109354 284
2021 1109354 224
2022 1109354 198
2023 1109354 263
2024 1109354 143
2025 1109354 27.3

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 15 fiscal years from 2010 to 2025 with positive net income, operating cash flow totaled $3,094 million against net income of $2,385 million, or 1.30 times. Net income was negative in 1 of the 16 years, and those years are left out of the ratio.

In 2025, net income was -$8.6 million and operating cash flow was $134 million, so no ratio is shown for that year.

In 2025, capital expenditures were $90.8 million, 67.7% of operating cash flow of $134 million, which leaves an estimated $43.3 million after capex. Across the 16 years with reported capex, it averaged 32.8% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2010 95.4 156 31.9 1.64
2011 92.3 87.7 61.6 0.95
2012 77.5 133 72.8 1.72
2013 80.1 145 50.3 1.81
2014 56.7 114 33.8 2.02
2015 102 229 34.2 2.26
2016 154 131 37.1 0.85
2017 78.6 154 43.7 1.96
2018 180 240 49.2 1.33
2019 197 213 12.3 1.08
2020 158 332 97.2 2.11
2021 277 282 92 1.02
2022 297 274 129 0.93
2023 427 350 107 0.82
2024 113 251 115 2.22
2025 -8.6 134 90.8 n/a

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $1,717 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In the 10 of those years with dividend payment facts, dividends paid totaled $225 million, 13.1% of the estimated free cash flow of those years. Estimated free cash flow was at least the dividends paid in 10 of those 10 years.

In 8 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $1,156 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, dividends and cash spent repurchasing shares together were $32.8 million, 120.3% of estimated free cash flow of $27.3 million. That was more than the estimated free cash flow of the year.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 85.2 25.8 160 186 218.2%
2017 115 6.4 152 159 138.4%
2018 200 6.3 n/a 6.3 3.1%
2019 178 25 142 167 93.9%
2020 284 24.6 123 148 52.0%
2021 224 24.2 153 178 79.4%
2022 198 29.8 263 293 147.6%
2023 263 29.4 152 182 69.2%
2024 143 30.2 n/a 30.2 21.1%
2025 27.3 22.8 10 32.8 120.3%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $1,115 million in 2009 and $3,437 million in 2025, a compound annual growth rate of 7.3% over 16 years.

Revenue rose 2.1% from 2024 to 2025.

Our estimated free cash flow was $27.3 million in 2025, 0.8% of revenue. In 2009 the estimated margin was 12.0%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2009 1,115 134 12.0%
2010 1,305 132 10.1%
2011 1,652 51.1 3.1%
2012 1,791 87.5 4.9%
2013 1,839 98.4 5.4%
2014 1,809 64.2 3.6%
2015 1,624 179 11.0%
2016 1,611 85.2 5.3%
2017 1,766 115 6.5%
2018 1,896 200 10.6%
2019 2,073 178 8.6%
2020 1,988 284 14.3%
2021 2,418 224 9.2%
2022 2,531 198 7.8%
2023 2,965 263 8.9%
2024 3,366 143 4.3%
2025 3,437 27.3 0.8%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $299 million against total liabilities of $3,731 million, or 8.0% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 59.8% of total assets in 2025, compared with 66.0% in 2010, a decrease of 6.2 percentage points.

Stockholders equity was $2,474 million in 2025, compared with $527 million in 2010, a rise of 369.0%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 0.6% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2010 1,550 230 1,022 527
2011 1,711 246 1,086 625
2012 1,856 311 1,147 710
2013 1,988 439 1,138 850
2014 1,865 320 1,093 772
2015 1,730 267 997 733
2016 1,808 342 1,115 693
2017 1,949 325 1,215 734
2018 2,129 322 1,201 905
2019 2,772 678 1,833 917
2020 3,049 682 2,075 974
2021 3,650 1,068 2,565 1,085
2022 3,612 646 2,480 1,126
2023 4,250 488 2,837 1,395
2024 5,807 183 3,992 1,797
2025 6,241 299 3,731 2,474

Price Versus Our Estimated Value

Every one of the 17 fiscal years we have for Bruker Corporation under its current filer shows positive free cash flow.

Average free cash flow over the last three years of data was $144 million, and across the first three years it was $106 million; over the period it rose sharply.

Free cash flow is volatile from year to year, with a variability measure of 45%.

At $63.26, Bruker Corporation trades above our fair value estimate of $16.08.

Its dividend yield is 0.08%.

Before you act on any of this, read what a margin of safety means and check the company's own filings.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 213% above the average for stocks in the Technology sector.

Its trailing P/E ratio is in line with the average for stocks in the Scientific & Technical Instruments industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Scientific & Technical Instruments industry, the ones closest in market capitalization to Bruker Corporation, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Bruker Corporation (BRKR) 9,661 - 0.1% - 293% above
Bio-Rad Laboratories (BIO) 9,633 9.5 - 0.8% 9% below
Onto Innovation (ONTO) 9,867 66.1 - - 370% above
Avantor (AVTR) 10,286 30.4 - - 85% above
Cognex Corporation (CGNX) 8,272 34.4 0.7% 1.3% 117% above
Trimble (TRMB) 12,365 - - 4.1% 18% below
Sensata Technologies Holding plc (ST) 5,464 15.0 1.3% 11.8% 59% below

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 1109354.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-18
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: BRKR annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in BRKR

Does Bruker Corporation have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: BRKR

This example shows how we apply the Trendshare checklist to BRKR: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 63.26
    • Market cap: $9.7B
    • EPS: -1.1
  2. Step 2 — Valuation checks

    • P/E: —
    • FCF yield: —
    • Date checked: Nov 18, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.